Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Review
  • Published:

Malignant hematopoietic cell lines: in vitro models for the study of natural killer cell leukemia–lymphoma

Leukemia volume 14, pages 777–782 (2000)Cite this article

Abstract

Malignancies involving natural killer (NK) cells are rare disorders. The complexity of NK cell-involving disorders has only recently been appreciated. Modern classifications discern immature (precursor) from mature NK cell leukemias–lymphomas. Continuous NK leukemia–lymphoma cell lines represent important model systems to study these neoplasms. While there are a number of putative NK cell lines which are, however, either not characterized, not immortalized, non-malignant, non-NK, or plain false cell lines, six bona fide malignant NK cell lines have been established and are sufficiently well characterized: HANK1, KHYG-1, NK-92, NKL, NK-YS and YT. Except for YT which was derived from a not further defined acute lymphoblastic lymphoma, these cell lines were established from patients with various NK cell malignancies. Five of the six cell lines are constitutively interleukin-2-dependent. Their immunoprofile is remarkably similar: CD1−, CD2+, surface CD3− (but cytoplasmic CD3ε+), CD4−, CD5−, CD7+, CD8−, CD16−, CD56+, CD57−, TCRαβ−, TCRγδ−, negative for B cell and myelomonocytic markers. The immunoglobulin heavy chain and T cell receptor genes are all in germline configuration. All six lines show complex chromosomal alterations, with both numerical and structural aberrations, attesting to their malignant and monoclonal nature. Functionally, these cells which contain azurophilic granules in their cytoplasm are nearly universally positive in NK activity assays. Three of five cell lines are Epstein–Barr virus-positive (type II latency). The composite data on these six cell lines allow for the operational definition of a typical malignant NK cell line profile. NK leukemia–lymphoma cell lines will prove invaluable for studies of normal and malignant NK cell biology.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

References

  1. Lamy T, Loughran TP Jr . Large granular lymphocyte leukemia Educational Program Book European Haematology Association 1998 pp 38–43

    Google Scholar 

  2. Trinchieri G . Biology of natural killer cells Adv Immunol 1989 47: 187–376

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  3. McKenna RW, Parkin J, Kersey JH, Gajl-Peczalska KJ, Peterson L, Brunning RD . Chronic lymphoproliferative disorder with unusual clinical, morphologic, ultrastructural and membrane surface marker characteristics Am J Med 1977 62: 588–595

    Article  CAS  PubMed  Google Scholar 

  4. Loughran TP Jr, Kadin ME, Starkebaum G, Abkowitz JL, Clark EA, Disteche C, Lum LG, Slichter SJ . Leukemia of large granular lymphocytes: association with clonal chromosomal abnormalities and autoimmune neutropenia, thrombocytopenia, and hemolytic anemia Ann Intern Med 1985 102: 169–175

    Article  PubMed  Google Scholar 

  5. Bennett JM, Catovsky D, Daniel MT, Flandrin G, Galton DAG, Gralnick HR, Sultan C . Proposals for the classification of chronic (mature) B and T lymphoid leukaemias J Clin Pathol 1989 42: 567–584

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  6. Loughran TP Jr . Clonal diseases of large granular lymphocytes Blood 1993 82: 1–14

    PubMed  Google Scholar 

  7. Harris NL, Jaffe ES, Stein H, Banks PM, Chan JKC, Cleary ML, Delsol G, De Wolf-Peeters C, Falini B, Gatter KC, Grogan TM, Isaacson PG, Knowles DM, Mason DY, Muller-Hermelink HK, Pileri SA, Piris MA, Ralfkiaer E, Warnke RA . A revised European–American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group Blood 1994 84: 1361–1392

    CAS  PubMed  Google Scholar 

  8. Agnarsson BA, Loughran TP, Starkebaum G, Kadin ME . The pathology of large granular lymphocyte leukemia Hum Pathol 1989 20: 643–651

    Article  CAS  PubMed  Google Scholar 

  9. Hercend T, Schmidt RE . Characteristics and uses of natural killer cells Immunol Today 1988 9: 291–293

    Article  CAS  PubMed  Google Scholar 

  10. Robertson MJ, Ritz J . Biology and clinical relevance of human natural killer cells Blood 1990 76: 2421–2438

    CAS  PubMed  Google Scholar 

  11. Lanier LL, Spits H, Phillips JH . The developmental relationship between NK cells and T cells Immunol Today 1992 13: 392–395

    Article  CAS  PubMed  Google Scholar 

  12. Pollack SB . Production and differentiation of NK lineage cells in bone marrow Nat Immun 1993 12: 177–193

    CAS  PubMed  Google Scholar 

  13. Spits H, Lanier LL, Phillips JH . Development of human T and natural killer cells Blood 1995 85: 2654–2670

    CAS  PubMed  Google Scholar 

  14. Pellici PG, Allavena P, Subar M, Rambaldi A, Pirelli A, Di Bello M, Barbui T, Knowles DM, Dalla-Favera R, Mantovani A . T-cell receptor (α, β, γ) gene rearrangements and expression distinguish large granular lymphocyte/natural killer cells and T-cells Blood 1987 70: 1500–1508

    Google Scholar 

  15. Oshimi K . Lymphoproliferative disorders of natural killer cells Int J Hematol 1996 63: 279–290

    Article  CAS  PubMed  Google Scholar 

  16. Trinchieri G . Interleukin-12: a cytokine produced by antigen-presenting cells with immunoregulatory functions in the generation of T-helper cells type 1 and cytotoxic lymphocytes Blood 1994 84: 4008–4027

    CAS  PubMed  Google Scholar 

  17. Lee SM, Suen Y, Qian J, Knoppel E, Cairo MS . The regulation and biological activity of interleukin-12 Leuk Lymphoma 1998 29: 427–438

    Article  CAS  PubMed  Google Scholar 

  18. Waldmann TA, Tagaya Y . The multifaceted regulation of interleukin-15 expression and the role of this cytokine in NK cell differentiation and host response to intracellular pathogens Annu Rev Immunol 1999 17: 19–49

    Article  CAS  PubMed  Google Scholar 

  19. Fehniger TA, Shah MH, Turner MJ, Van Deusen JB, Whitman SP, Cooper MA, Suzuki K, Wechser M, Goodsaid F, Caligiuri MA . Differential cytokine and chemokine gene expression by human NK cells following activation with IL-18 or IL-15 in combination with IL-2: implications for the innate immune response J Immunol 1999 162: 4511–4520

    CAS  PubMed  Google Scholar 

  20. Jaffe ES . Classification of natural killer (NK) cell and NK-like T-cell malignancies Blood 1996 87: 1207–1210

    CAS  PubMed  Google Scholar 

  21. Suzuki R, Nakamura S . Malignancies of natural killer (NK) cell precursor: Myeloid/NK cell precursor acute leukemia and blastic NK cell lymphoma/leukemia Leukemia Res 1999 23: 615–624

    Article  CAS  Google Scholar 

  22. Scott AA, Head DR, Kopecky KJ, Appelbaum FR, Theil KS, Grever MR, Chen IM, Whittaker MH, Griffith BB, Licht JD, Waxman S, Whalen MM, Bankhurst AD, Richter LC, Grogan TM, Willman CL . HLA-DR−, CD33+, CD56+, CD16− myeloid/natural killer cell acute leukemia: a previously unrecognized form of acute leukemia potentially misdiagnosed as French-American-British acute myeloid leukemia-M3 Blood 1994 84: 244–255

    CAS  PubMed  Google Scholar 

  23. Wong KF, Zhang YM, Chan JKC . Cytogenetic abnormalities in natural killer cell lymphoma–leukemia – is there a consistent pattern? Leuk Lymphoma 1999 34: 241–250

    Article  CAS  PubMed  Google Scholar 

  24. Kanegane H, Yachie A, Miyawaki T, Tosato G . EBV-NK cells interactions and lymphoproliferative disorders Leuk Lymphoma 1998 29: 491–498

    Article  CAS  PubMed  Google Scholar 

  25. Kagami Y, Nakamura S, Suzuki R, Iida S, Yatabe Y, Okada Y, Kobayashi T, Tsurumi T, Seto M, Ogura M, Taguchi O, Morishima Y . Establishment of an IL-2-dependent cell line derived from ‘nasal-type’ NK/T-cell lymphoma of CD2+, sCD3−, CD3ε+, CD56+ phenotype and associated with the Epstein-Barr virus Br J Haematol 1998 103: 669–677

    Article  CAS  PubMed  Google Scholar 

  26. Yagita M, Huang CL, Umehara H, Matsuo Y, Tabata R, Miyake M, Konaka Y, Takatsuki K . A novel natural killer cell line from a patient with aggressive natural killer cell leukemia carrying a p53 point mutation Leukemia 2000 14: 922–930

    Article  CAS  PubMed  Google Scholar 

  27. Gong JH, Maki G, Klingemann HG . Characterization of a human cell line (NK-92) with phenotypical and functional characteristics of activated natural killer cells Leukemia 1994 8: 652–658

    CAS  PubMed  Google Scholar 

  28. Robertson MJ, Cochran KJ, Cameron C, Le JM, Tantravahi R, Ritz J . Characterization of a cell line, NKL, derived from an aggressive human natural killer leukemia Exp Hematol 1996 24: 406–415

    CAS  PubMed  Google Scholar 

  29. Tsuchiyama J, Yoshino T, Mori M, Kondoh E, Oka T, Akagi T, Hiraki A, Nakayama H, Shibuya A, Ma YX, Kawabata T, Okada S, Harada M . Characterization of a novel human natural killer-cell line (NK-YS) established from natural killer cell lymphoma/leukemia associated with Epstein–Barr virus infection Blood 1998 92: 1374–1383

    CAS  PubMed  Google Scholar 

  30. Yodoi J, Teshigawara K, Nikaido T, Fukui K, Noma T, Honjo T, Takigawa M, Sasaki M, Minato N, Tsudo M, Uchiyama T, Maeda M . TCGF (IL-2)-receptor inducing factor(s). I. Regulation of IL 2 receptor on a natural killer-like cell line (YT cells) J Immunol 1985 134: 1623–1630

    CAS  PubMed  Google Scholar 

  31. Yoneda N, Tatsumi E, Kawano S, Teshigawara K, Oka T, Fukuda M, Yamaguchi N . Detection of Epstein–Barr virus genome in natural-killer-like cell line, YT Leukemia 1992 6: 136–141

    CAS  PubMed  Google Scholar 

  32. Drexler HG, Dirks WG, MacLeod RAF, Quentmeier H, Steube KG, Uphoff CC (eds) . DSMZ Catalogue of Human and Animal Cell Lines 7th edn. Braunschweig, Germany 1999

    Google Scholar 

  33. Asada H, Okada N, Hashimoto K, Yamanishi K, Sairenji T, Hirota S, Nomura S, Kitamura Y, Yoshikawa K . Establishment and characterization of the T-cell line, EBT-8 latently infected with Epstein–Barr virus from large granular lymphocyte leukemia Leukemia 1994 8: 1415–1423

    CAS  PubMed  Google Scholar 

  34. Hsi ED, Alkan S, Wang I, Sheldon S, Nickoloff BJ, Wrone-Smith T . Cytokine profiles and differential effect of IL-2 on two new NK lymphoma cell lines Blood 1997 90: 258b

    Google Scholar 

  35. Tsuge I, Morishima T, Morita M, Kimura H, Kuzushima K, Matsuoka H . Characterization of Epstein-Barr virus (EBV)-infected natural killer cell proliferation in patients with severe mosquito allergy: establishment of an IL-2-dependent NK-like cell line Clin Exp Immunol 1999 115: 385–392

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  36. Takiguchi T, Sakuma M, Kim C, Ogawa Y, Takeshita S, Masaki Y, Fukutoku M, Hirose Y, Sugai S . In vitro differentiation of 2 myeloid leukemia cell lines and the effect of anti-proliferative activity by TGF-β Br J Haematol 1998 102: 24

    Google Scholar 

  37. Kornbluth J, Flomenberg N, Dupont B . Cell surface phenotype of a cloned line of human natural killer cells J Immunol 1982 129: 2831–2837

    CAS  PubMed  Google Scholar 

  38. Zhou J, Olsen S, Moldovan J, Fu X, Sarkar FH, Moudgil VK, Callewaert DM . Glucocorticoid regulation of natural cytotoxicity: effects of cortisol on the phenotype and function of a cloned human natural killer cell line Cell Immunol 1997 178: 108–116

    Article  CAS  PubMed  Google Scholar 

  39. Sahraoui Y, Perraki M, Theodoropoulou M, Allouche M, Tsapis A, Ammar A, Clemenceau C, Bokogiorgou S, Yacci T, Katrinakis G, Jasmin C, Georgoulias V . Autocrine IL-2-dependent growth of a newly established CD3+, CD16−, CD56+, CD57+, JH−, TCRβ−, TCRγ− leukemia cell line (NOI-90) Leukemia 1997 11: 245–252

    Article  CAS  PubMed  Google Scholar 

  40. Komiyama A, Kawai H, Miyagawa Y, Akabane T . Childhood lymphoblastic leukemia with natural killer activity: establishment of the leukemia cell lines retaining the activity Blood 1982 60: 1429–1436

    CAS  PubMed  Google Scholar 

  41. Komiyama A, Yamada S, Kawai H, Miyagawa Y, Akabane T . Childhood acute lymphoblastic leukemia with natural killer activity. Clinical and cellular features of three cases Cancer 1984 54: 1547–1553

    Article  CAS  PubMed  Google Scholar 

  42. Gignac SM, Steube K, Schleithoff L, Janssen JWG, MacLeod RAF, Quentmeier H, Drexler HG . Multiparameter approach in the identification of cross-contaminated leukemia cell lines Leuk Lymphoma 1993 10: 359–368

    Article  CAS  PubMed  Google Scholar 

  43. Drexler HG, Dirks WG, MacLeod RAF . False human hematopoietic cell lines: cross-contaminations and misinterpretations Leukemia 1999 13: 1601–1607

    Article  CAS  PubMed  Google Scholar 

  44. Santoli D, O'Connor R, Cessano A, Phillips P, Colt TL, Lange B, Clark SC, Rovera G . Synergistic and antagonistic effects of IL-1α and IL-4, respectively, on the IL-2-dependent growth of a T cell receptor-γδ+ human T leukemia cell line J Immunol 1990 144: 4703–4711

    CAS  PubMed  Google Scholar 

  45. O'Connor R, Cesano A, Kreider BL, Lange B, Clark SC, Nowell PC, Finan J, Rovera G, Santoli D . Growth factor-dependent differentiation along the myeloid and lymphoid lineages in an immature acute T lymphocytic leukemia J Immunol 1990 145: 3779–3787

    CAS  PubMed  Google Scholar 

  46. O'Connor R, Cesano A, Lange B, Finan J, Nowell PC, Clark SC, Raimondi SC, Rovera G, Santoli D . Growth factor requirements of childhood T-lymphoblastic leukemia: correlation between presence of chromosomal abnormalities and ability to grow permanently in vitro Blood 1991 77: 1534–1545

    CAS  PubMed  Google Scholar 

  47. Cesano A, O'Connor R, Lange B, Finan J, Rovera G, Santoli D . Homing and progression patterns of childhood acute lymphoblastic leukemias in severe combined immunodeficiency mice Blood 1991 77: 2463–2474

    CAS  PubMed  Google Scholar 

  48. Cesano A, O'Connor R, Nowell PC, Lange B, Clark SC, Santoli D . Establishment of a karyotypically normal cytotoxic leukemic T-cell line from a T-ALL sample engrafted in SCID mice Blood 1993 81: 2714–2722

    CAS  PubMed  Google Scholar 

  49. Kojima H, Suzukawa K, Yatabe Y, Hori M, Nagasawa T, Abe T . Establishment of a new natural killer (NK) cell line, TKS-1, from a patient with aggressive type of large granular lymphocyte (LGL) leukemia Leukemia 1994 8: 1999–2004

    CAS  PubMed  Google Scholar 

  50. Fernandez LA, Pope B, Lee C, Zayed E . Aggressive natural killer cell leukemia in an adult with establishment of an NK cell line Blood 1986 67: 925–930

    CAS  PubMed  Google Scholar 

  51. Pistoia V, Carroll AJ, Prasthofer EF, Tilden AB, Zuckerman KS, Ferrarini M, Grossi CE . Establishment of Tac-negative, interleukin-2-dependent cytotoxic cell lines from large granular lymphocytes (LGL) of patients with expanded LGL populations J Clin Immunol 1986 6: 457–466

    Article  CAS  PubMed  Google Scholar 

  52. Drexler HG, Matsuo Y . Guidelines for the characterization and publication of human malignant hematopoietic cell lines Leukemia 1999 13: 835–842

    Article  CAS  PubMed  Google Scholar 

  53. Drexler HG, Fombonne S, Matsuo Y, Hu ZB, Hamaguchi H, Uphoff CC . p53 alterations in human leukemia–lymphoma cell lines: In vitro artifact or prerequisite for cell immortalization? Leukemia 2000 14: 198–206

    Article  CAS  PubMed  Google Scholar 

  54. Drexler HG (ed) . The Leukemia–Lymphoma Cell Lines FactsBook Academic Press: San Diego 2000 (in press)

  55. Richards SJ, Scott CS . Human NK cells in health and disease: clinical, functional, phenotypic and DNA genotypic characteristics Leuk Lymphoma 1992 7: 377–400

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Human and Animal Cell Cultures, DSMZ-German Collection of Microorganisms and Cell Cultures, Braunschweig, Germany

    HG Drexler

  2. Fujisaki Cell Center, Hayashibara Biochemical Laboratories, Okayama, Japan

    Y Matsuo

Authors
  1. HG Drexler
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Y Matsuo
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Drexler, H., Matsuo, Y. Malignant hematopoietic cell lines: in vitro models for the study of natural killer cell leukemia–lymphoma. Leukemia 14, 777–782 (2000). https://doi.org/10.1038/sj.leu.2401778

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.leu.2401778

Keywords

This article is cited by

Search

Advanced search

Quick links